REKAMBYS 600 mg / 2 ml, Depot-Injektionssuspension
7680677420016
CH-67742
J05AG05
08.03.0.
Reimbursement limitations:
REKAMBYS
REKAMBYS Suspension injectable est remboursé exclusivement en association avec le cabotégravir injectable dans le traitement …
1 / 3
google
Details
- Product number
- 6774201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg.
Articles (1)
REKAMBYS 600 mg / 2 ml, Depot-Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.66 MG | Substance | HBESI |
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67742
- Drug name
- REKAMBYS, Depot-Injektionssuspension
- Galenic form
- INLFS
- ATC Code
- J05AG05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/10/2021
- Authorization expiration date
- 07/10/2026
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REKAMBYS Depot susp inj 600 mg/2ml flac 2 ml
- Description (DE)
- REKAMBYS Depot Inj Susp 600 mg/2ml Durchstf 2 ml
- Narcotic (BTM)
- No